基于CRISPR/Cas系统的DNA碱基编辑技术及其在生物医学和农业中的应用

近年来,基于成簇的规律间隔短回文重复序列及其相关系统(Clustered regularly interspaced short palindromic repeats/CRISPR-associated protein,CRISPR/Cas)的基因编辑技术飞速发展,该系统可以利用同源定向重组(Homology directed repair,HDR)来完成其介导的精准编辑,但效率极低,限制了其在农业和生物医学等领域上的推广应用。基于CRISPR/Cas系统的DNA碱基编辑技术作为一种新兴的基因组编辑技术,能在不产生双链断裂的情况下实现碱基的定向突变,相对于CRISPR/Cas介导的HDR编辑具有更高的编辑效率和特异性。目前,已开发出了可将C碱基突变为T碱基的胞嘧啶碱基编辑器(Cytidine base editors,CBE),将A碱基突变为G碱基的腺嘌呤碱基编辑器(Adenine base editors,ABE),以及可实现碱基任意变换和小片段精准插入和缺失的Prime编辑器(Prime editors,PE)。另外,能实现C到G颠换的糖基化酶碱基编辑器(Glycosylase base editors,GBE)以及能同时编辑A和C两种底物的双碱基编辑器也已被开发出来。文中主要综述了几种DNA碱基编辑器的开发历程、研究进展及各自优点和局限性;介绍了DNA碱基编辑技术在生物医学以及农业中的成功应用案例,以期为DNA碱基编辑器的进一步优化和选择应用提供借鉴。     

BE3型胞嘧啶碱基编辑器在谷氨酸棒杆菌中的开发及应用

碱基编辑技术结合了CRISPR/Cas系统的靶向特异性与碱基脱氨酶的催化活性,因其不产生双链DNA断裂、不需要外源DNA模板、不依赖同源重组修复,自开发以来,便受到研究者的追捧,在哺乳动物细胞、植物、微生物等领域相继得到开发与应用。为了进一步丰富碱基编辑系统在谷氨酸棒杆菌中的应用,将鼠源胞嘧啶脱氨酶(rAPOBEC1)与nCas9蛋白融合,实现了在谷氨酸棒杆菌中C到T的编辑,编辑比例较低(0-20%);在上述融合蛋白C端添加UGI蛋白,构建BE3型胞嘧啶碱基编辑器,抑制体内的DNA碱基切除修复机制,显著的提高了碱基编辑效率,使得C到T的碱基编辑效率高达90%;为了简化操作,将双质粒碱基编辑系统优化为单质粒碱基编辑系统,并显著提高转化效率;最后通过单质粒碱基编辑系统对基因组中其他位点的编辑测试,进一步证明了BE3型碱基编辑器在谷氨酸棒杆菌中的高效性,同时发现该碱基编辑器具有较宽的编辑窗口(PAM上游-11到-19位),有助于覆盖更多的基因组靶标位点,为谷氨酸棒杆菌的基因组改造提供了更多的工具选择。     

碱基编辑技术的发展与应用

碱基编辑技术,以CRISPR/Cas系统为平台,引导胞嘧啶脱氨酶或腺嘌呤脱氨酶至特定的基因组靶点,产生靶向性的C至T或者A至G的碱基转换。自碱基编辑技术问世以来,全球多个科研团队通过优化改进得到了一系列高精准性、广靶向性、小编辑框、普适性的碱基编辑器。在应用方面,碱基编辑器能够在人体细胞、动植物细胞以及胚胎中进行高效的碱基转换,在治疗人类遗传病、构建动物疾病模型、植物育种等方面具有巨大的应用潜能。本文就碱基编辑技术的发展、优化和应用等方面进行综述和展望。     

碱基编辑器的开发及其在细菌基因组编辑中的应用

碱基编辑器是近两年发展起来的新型基因组编辑工具,它将碱基脱氨酶的催化活性和CRISPR/Cas系统的靶向特异性进行结合,催化DNA或RNA链上特定位点的碱基发生脱氨基反应,进而完成碱基的替换。碱基编辑器分为DNA和RNA碱基编辑器两大类,其中DNA碱基编辑器分为两种:胞嘧啶碱基编辑器和腺嘌呤碱基编辑器;前者可以实现胞嘧啶到胸腺嘧啶的转换,而后者则可以将腺嘌呤突变为鸟嘌呤。由于DNA碱基编辑器不会造成DNA的双链断裂(DSB),也不依赖于宿主的非同源末端修复和同源重组途径,因此,大大减少了DSB相关的编辑副产物,如小片段插入或缺失等。基于CRISPR/Cas系统的RNA碱基编辑器,可以实现RNA链上腺嘌呤核苷到次黄苷的转换。本文对不同类型碱基编辑器的开发过程、适用范围和编辑特点等进行梳理,并对其在细菌基因组编辑中的应用进行了介绍;最后简要探讨了细菌中碱基编辑器的缺点以及将来可能的研究方向。     

CRISPR-Cas核酸酶及其人工改造变体和单碱基编辑器在植物中的应用

规律间隔成簇短回文重复序列(CRISPR)-CRISPR相关蛋白(Cas)和单碱基编辑器是植物基因编辑的基本工具。来自酿脓链球菌的Cas9(SpCas9)可以识别NGG前间区序列邻近基序(PAM),是一种广泛应用于活细胞基因组编辑的核酸酶。Cas12a核酸酶最近也在多种植物中实现了靶向识别富含T的PAM序列。     

新型隐球酵母U6启动子的鉴定、克隆及功能验证

【目的】鉴定及克隆新型隐球酵母(Cryptococcus neoformans)中PolⅢ型的U6启动子(Cn U6启动子),并验证CnU6启动子能否有效转录shRNA及CRISPR/Cas9系统中gRNA。【方法】结合Gen Bank数据库已公布的新型隐球酵母基因组信息和本实验室RNA-seq文库数据,利用生物信息学技术分析得到新型隐球酵母中具有高转录水平的U6RNA序列。使用重叠PCR和Easy Geno方法将预测的CnU6启动子分别克隆到sh RNA及gRNA的上游区域,通过观察shRNA对靶基因的RNAi效果及gRNA引导Cas9核酸酶对靶位点的切割结果,确定CnU6启动子能否转录短RNA。【结果】CnU6启动子能够转录形成shRNA对靶基因进行沉默,并且能转录形成g RNA引导Cas9核酸酶对靶点进行切割。【结论】新型隐球酵母的CnU6启动子被成功鉴定及克隆,它能有效驱动shRNA和gRNA的转录。     

碱基编辑系统研究最新进展及应用

CRISPR系统能够在基因组DNA中完成精准编辑,但依赖于细胞内的同源重组(Homologydirected recombination,HDR)修复途径,且效率极低。基于CRISPR/Cas9系统开发的碱基编辑技术(Base editing)通过将失去切割活性的核酸酶与不同碱基脱氨基酶融合,构建了两套碱基编辑系统(Baseeditors,BE):胞嘧啶碱基编辑器(Cytosine base editor,CBE)和腺嘌呤碱基编辑器(Adenine base editor,ABE)。这两类编辑器分别能够在不产生DNA双链断裂的前提下在基因靶位点完成CT (GA)或AG (TC)的替换,最终实现精准的碱基编辑。目前碱基编辑技术已经广泛应用于基因治疗、动物模型构建、精准动物育种和基因功能分析等领域,为基础和应用研究提供了强大的技术工具。文中概括了碱基编辑技术的研发过程、技术优势、应用现状、存在问题及改进策略,以期为相关领域的科研人员了解和使用碱基编辑系统提供参考。     

谷氨酸棒杆菌中胞嘧啶碱基编辑工具的PAM拓展

碱基编辑是一种新兴的基因组编辑技术，具有不产生双键断裂、不依赖同源重组且不需要添加外源模板的优势，在真核及原核生物中得到了广泛的开发与应用。为了进一步扩展碱基编辑技术在谷氨酸棒杆菌中的基因组覆盖范围，本研究将3种PAM限制较为宽松的新型Cas9突变体应用于胞嘧啶碱基编辑工具中，分别为近乎PAMless的SpRY突变体（NRN>NYN PAM）、SpG突变体（NGN PAM），以及ScCas9++蛋白（NNG PAM），实现对碱基编辑工具的PAM拓展。结合SpRY突变体的碱基编辑系统展示出了更宽松的PAM识别，除对CAT、CAC、TAA PAM的位点完全没有编辑外，对其他NRN种类的PAM位点均出现了不同程度的识别，但整体编辑效率低，难以推广应用；结合SpG突变体的碱基编辑系统可实现对所有NGN种类PAM位点的编辑，且编辑效率优于SpRY突变体，但对NGG PAM位点的编辑，相比原始Cas9蛋白，编辑效率下降9.3%-55.9%；结合ScCas9++蛋白的碱基编辑系统，除对TCG、CTG PAM的基因组位点没有编辑外，可实现对其他测试NNG PAM的基因组位点编辑，大部分位点基因组...     

中国科学家发现胞嘧啶单碱基编辑工具存在 基因组范围的脱靶

基于CRISPR-Cas的单碱基编辑工具是近2年基因组编辑技术的重大突破之一, 已经在人类(Homo sapiens)细胞和动植物中得到了验证与应用。最近, 中国科学家分析了胞嘧啶编辑器(CBE) BE3和HF1-BE3, 以及腺嘌呤编辑器(ABE)等单碱基编辑工具在水稻(Oryza sativa)中的脱靶现象, 发现BE3和HF1-BE3两个CBE在全基因组范围内存在脱靶编辑, 而ABE则没有脱靶现象。这一发现对单碱基编辑工具的应用和进一步改进具有重要意义。     

毕赤酵母基因编辑技术研究进展

巴斯德毕赤酵母是一种重要的蛋白表达系统,基因编辑技术作为代谢工程的基本工具,对于毕赤酵母的代谢改造十分重要。近十年基因编辑技术发展迅速,除传统的同源重组和Cre/loxP重组外,相继出现了许多新的基因编辑技术,例如ZFN、TALEN和CRISPR/Cas9等,这些技术的出现使基因编辑更加简便高效。本文对毕赤酵母中传统和新型基因编辑技术的原理应用和研究进展进行了简要综述,并结合相关领域的发展对毕赤酵母基因编辑技术的发展进行了展望。     

Expanding the CRISPR/Cas9 toolkit for Pichia pastoris with efficient donor integration and alternative resistance markers

Komagataella phaffii (syn. Pichia pastoris) is one of the most commonly used host systems for recombinant protein expression. Achieving targeted genetic modifications had been hindered by low frequencies of homologous recombination (HR). Recently, a CRISPR/Cas9 genome editing system has been implemented for P. pastoris enabling gene knockouts based on indels (insertion, deletions) via non‐homologous end joining (NHEJ) at near 100% efficiency. However, specifically integrating homologous donor cassettes via HR for replacement studies had proven difficult resulting at most in ～20% correct integration using CRISPR/Cas9. Here, we demonstrate the CRISPR/Cas9 mediated integration of markerless donor cassettes at efficiencies approaching 100% using a ku70 deletion strain. The Ku70p is involved in NHEJ repair and lack of the protein appears to favor repair via HR near exclusively. While the absolute number of transformants in the Δku70 strain is reduced, virtually all surviving transformants showed correct integration. In the wildtype strain, markerless donor cassette integration was also improved up to 25‐fold by placing an autonomously replicating sequence (ARS) on the donor cassette. Alternative strategies for improving donor cassette integration using a Cas9 nickase variant or reducing off targeting associated toxicity using a high fidelity Cas9 variant were so far not successful in our hands in P. pastoris. Furthermore we provide Cas9/gRNA expression plasmids with a Geneticin resistance marker which proved to be versatile tools for marker recycling. The reported CRSIPR‐Cas9 tools can be applied for modifying existing production strains and also pave the way for markerless whole genome modification studies in P. pastoris.     

A CRISPR/Cas9-mediated gene knockout system in Aspergillus luchuensis mut. kawachii

ABSTRACT

We developed an approach to genome editing of the white koji fungus, Aspergillus luchuensis mut. kawachii using clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system. Co-transformation of AMA1-based Cas9 and gRNA expression plasmids achieved efficient gene knockout in A. kawachii. The plasmids were easily lost when selective pressure was removed, allowing for successive rounds of genome editing.     

High‐efficient and precise base editing of C•G to T•A in the allotetraploid cotton (Gossypium hirsutum) genome using a modified CRISPR/Cas9 system

The base‐editing technique using CRISPR/nCas9 (Cas9 nickase) or dCas9 (deactivated Cas9) fused with cytidine deaminase is a powerful tool to create point mutations. In this study, a novel G. hirsutum‐Base Editor 3 (GhBE3) base‐editing system has been developed to create single‐base mutations in the allotetraploid genome of cotton (Gossypium hirsutum). A cytidine deaminase sequence (APOBEC) fused with nCas9 and uracil glycosylase inhibitor (UGI) was inserted into our CRISPR/Cas9 plasmid (pRGEB32‐GhU6.7). Three target sites were chosen for two target genes, GhCLA and GhPEBP, to test the efficiency and accuracy of GhBE3. The editing efficiency ranged from 26.67 to 57.78% at the three target sites. Targeted deep sequencing revealed that the C→T substitution efficiency within an ‘editing window’, approximately six‐nucleotide windows of ?17 to ?12 bp from the PAM sequence, was up to 18.63% of the total sequences. The 27 most likely off‐target sites predicted by CRISPR‐P and Cas‐OFFinder tools were analysed by targeted deep sequencing, and it was found that rare C→T substitutions (average < 0.1%) were detected in the editing windows of these sites. Furthermore, whole‐genome sequencing analyses on two GhCLA‐edited and one wild‐type plants with about 100× depth showed that no bona fide off‐target mutations were detectable from 1500 predicted potential off‐target sites across the genome. In addition, the edited bases were inherited to T1 progeny. These results demonstrate that GhBE3 has high specificity and accuracy for the generation of targeted point mutations in allotetraploid cotton.     

分枝杆菌LY-1内源性表达元件的筛选及其在降低Cas9蛋白毒性中的应用

【背景】分枝杆菌LY-1因能够将天然植物甾醇代谢转化为重要甾体药物中间体,目前已成为工业上的优势生产菌株。高效的CRISPR/Cas9基因编辑技术是工业菌株代谢工程改造进行产量性状提升的关键。然而由于Cas9蛋白的高表达毒性问题且分枝杆菌中已公开报道的可用表达元件较少,极大地限制了Cas9蛋白在该菌株中的适度表达。【目的】筛选内源性表达元件,利用合适的表达元件启动Cas9蛋白的表达,降低其对菌株的毒性。【方法】依据文献和前期研究获得的分枝杆菌基因转录组水平数据,并结合启动子在线预测网站BDGP(https://www.fruitfly.org/seq＿tools/promoter.html),筛选内源性表达元件。以增强型绿色荧光蛋白作为报告基因对表达元件的强度进行评估,并采用不同强度的表达元件启动Cas9蛋白的表达。【结果】获得了23个不同表达强度的表达元件,采用中等强度的表达元件及弱表达元件都降低了Cas9蛋白对分枝杆菌LY-1的毒性,实现了Cas9蛋白在该菌株中的适度表达。【结论】建立了分枝杆菌LY-1内源性表达元件库,为后续菌株中高效CRISPR/Cas9基因编辑技术的构建及关键...     

Activities and specificities of CRISPR/Cas9 and Cas12a nucleases for targeted mutagenesis in maize

CRISPR/Cas9 and Cas12a (Cpf1) nucleases are two of the most powerful genome editing tools in plants. In this work, we compared their activities by targeting maize glossy2 gene coding region that has overlapping sequences recognized by both nucleases. We introduced constructs carrying SpCas9‐guide RNA (gRNA) and LbCas12a‐CRISPR RNA (crRNA) into maize inbred B104 embryos using Agrobacterium‐mediated transformation. On‐target mutation analysis showed that 90%–100% of the Cas9‐edited T0 plants carried indel mutations and 63%–77% of them were homozygous or biallelic mutants. In contrast, 0%–60% of Cas12a‐edited T0 plants had on‐target mutations. We then conducted CIRCLE‐seq analysis to identify genome‐wide potential off‐target sites for Cas9. A total of 18 and 67 potential off‐targets were identified for the two gRNAs, respectively, with an average of five mismatches compared to the target sites. Sequencing analysis of a selected subset of the off‐target sites revealed no detectable level of mutations in the T1 plants, which constitutively express Cas9 nuclease and gRNAs. In conclusion, our results suggest that the CRISPR/Cas9 system used in this study is highly efficient and specific for genome editing in maize, while CRISPR/Cas12a needs further optimization for improved editing efficiency.     

Double nicking by RNA-directed Cascade-nCas3 for high-efficiency large-scale genome engineering

New CRISPR-based genome editing technologies are developed to continually drive advances in life sciences, which, however, are predominantly derived from systems of Type II CRISPR-Cas9 and Type V CRISPR-Cas12a for eukaryotes. Here we report a novel CRISPR-n(nickase)Cas3 genome editing tool established upon a Type I-F system. We demonstrate that nCas3 variants can be created by alanine-substituting any catalytic residue of the Cas3 helicase domain. While nCas3 overproduction via plasmid shows severe cytotoxicity, an in situ nCas3 introduces targeted double-strand breaks, facilitating genome editing without visible cell killing. By harnessing this CRISPR-nCas3 in situ gene insertion, nucleotide substitution and deletion of genes or genomic DNA stretches can be consistently accomplished with near-100% efficiencies, including simultaneous removal of two large genomic fragments. Our work describes the first establishment of a CRISPR-nCas3-based genome editing technology, thereby offering a simple, yet useful approach to convert the naturally most abundantly occurring Type I systems into advanced genome editing tools to facilitate high-throughput prokaryotic engineering.     

Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos

Recent advances with the type II clustered regularly interspaced short palindromic repeats (CRISPR) system promise an improved approach to genome editing. However, the applicability and efficiency of this system in model organisms, such as zebrafish, are little studied. Here, we report that RNA-guided Cas9 nuclease efficiently facilitates genome editing in both mammalian cells and zebrafish embryos in a simple and robust manner. Over 35% of site-specific somatic mutations were found when specific Cas/gRNA was used to target either etsrp, gata4 or gata5 in zebrafish embryos in vivo. The Cas9/gRNA efficiently induced biallelic conversion of etsrp or gata5 in the resulting somatic cells, recapitulating their respective vessel phenotypes in etsrp^y11 mutant embryos or cardia bifida phenotypes in fau^tm236a mutant embryos. Finally, we successfully achieved site-specific insertion of mloxP sequence induced by Cas9/gRNA system in zebrafish embryos. These results demonstrate that the Cas9/gRNA system has the potential of becoming a simple, robust and efficient reverse genetic tool for zebrafish and other model organisms. Together with other genome-engineering technologies, the Cas9 system is promising for applications in biology, agriculture, environmental studies and medicine.     

Anti‐HIV‐1 potency of the CRISPR/Cas9 system insufficient to fully inhibit viral replication

The range of genome‐editing tools has recently been expanded. In particular, an RNA‐guided genome‐editing tool, the clustered regularly interspaced short palindromic repeat (CRISPR)‐associated 9 (Cas9) system, has many applications for human diseases. In this study, guide RNA (gRNA) to target gag, pol and a long terminal repeat of HIV‐1 was designed and used to generate gRNA‐expressing lentiviral vectors. An HIV‐1‐specific gRNA and Cas9 were stably dually transduced into a highly HIV‐1‐susceptible human T‐cell line and the inhibitory ability of the anti‐HIV‐1 CRISPR/Cas9 lentiviral vector assessed. Although clear inhibition of the early phase of HIV‐1 infection was observed, as evaluated by a VSV‐G‐pseudotyped HIV‐1 reporter system, the anti‐HIV‐1 potency in multiple rounds of wild type (WT) viral replication was insufficient, either because of generation of resistant viruses or overcoming of the activity of the WT virus. Thus, there are potential difficulties that must be addressed when considering anti‐HIV‐1 treatment with the CRISPR/Cas9 system alone.     

一种新型的CRISPR/Cas9-hLacI双链DNA供体适配基因编辑系统

在CRISPR/Cas9系统介导的基因编辑中,借助于双链DNA （double-stranded DNA,dsDNA）供体模板的重组效应能够实现对目标基因组靶位点的精确编辑和基因敲入,然而高等真核生物细胞中同源重组的低效性限制了该基因编辑策略的发展和应用。为提高CRISPR/Cas9系统介导dsDNA供体模板的同源重组效率,本研究利用大肠杆菌（Escherichia coli）乳糖操纵子阻遏蛋白LacI与操纵序列LacO特异性结合的特点,通过重组DNA技术将密码子人源化优化的阻遏蛋白基因LacI分别与脓链球菌（Streptococcus pyogenes）源的SpCas9和路邓葡萄球菌（Staphylococcus lugdunensis）源的SlugCas9-HF融合表达,通过PCR将操纵序列LacO与dsDNA供体嵌合,构建了新型的CRISPR/Cas9-hLacI供体适配系统（donor adapting system,DAS）。首先在报告载体水平上对Cas9核酸酶活性、DAS介导的同源引导修复（homology-directed repair,HDR）效率进行了验证和优化,其次在基因组水平对其介导的基因精确编辑进行了检测,并最终利用CRISPR/SlugCas9-hLacI DAS在HEK293T细胞中实现了VEGFA位点的精确编辑,效率高达30.5%,显著高于野生型。综上所述,本研究开发了新型的CRISPR/Cas9-hLacI供体适配基因编辑系统,丰富了CRISPR/Cas9基因编辑技术种类,为以后的基因编辑及分子设计育种研究提供了新的工具。